Nirmal Banda
Concepts (339)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Experimental | 30 | 2021 | 128 | 7.500 |
Why?
| Complement Activation | 20 | 2025 | 376 | 4.170 |
Why?
| Complement Pathway, Alternative | 13 | 2020 | 118 | 3.510 |
Why?
| Arthritis, Rheumatoid | 15 | 2025 | 1092 | 3.410 |
Why?
| Complement Pathway, Mannose-Binding Lectin | 8 | 2020 | 23 | 2.820 |
Why?
| Complement System Proteins | 12 | 2024 | 313 | 2.610 |
Why?
| Mannose-Binding Protein-Associated Serine Proteases | 7 | 2020 | 17 | 2.510 |
Why?
| Complement Factor H | 6 | 2025 | 72 | 2.120 |
Why?
| Synovial Membrane | 6 | 2025 | 90 | 1.880 |
Why?
| Complement C3 | 15 | 2024 | 203 | 1.600 |
Why?
| Complement Factor D | 6 | 2020 | 28 | 1.530 |
Why?
| Mice, Knockout | 23 | 2021 | 2871 | 1.190 |
Why?
| Collagen Type II | 8 | 2019 | 47 | 1.130 |
Why?
| Receptors, Complement 3b | 3 | 2023 | 82 | 0.950 |
Why?
| Antigen-Antibody Complex | 4 | 2017 | 84 | 0.910 |
Why?
| Mice, Inbred C57BL | 23 | 2021 | 5440 | 0.900 |
Why?
| Mice | 47 | 2023 | 16937 | 0.890 |
Why?
| Complement C5 | 4 | 2015 | 77 | 0.880 |
Why?
| Joints | 5 | 2020 | 100 | 0.860 |
Why?
| Receptor, Anaphylatoxin C5a | 2 | 2015 | 30 | 0.850 |
Why?
| Meniscus | 1 | 2023 | 21 | 0.820 |
Why?
| Dextrans | 5 | 2024 | 82 | 0.790 |
Why?
| Receptors, Complement 3d | 4 | 2023 | 140 | 0.740 |
Why?
| Anterior Cruciate Ligament Injuries | 1 | 2023 | 140 | 0.720 |
Why?
| Receptors, Complement | 3 | 2018 | 122 | 0.720 |
Why?
| RNA, Small Interfering | 4 | 2020 | 587 | 0.710 |
Why?
| Single-Chain Antibodies | 1 | 2020 | 16 | 0.700 |
Why?
| Synoviocytes | 1 | 2020 | 10 | 0.700 |
Why?
| Animals | 51 | 2023 | 35361 | 0.680 |
Why?
| Osteoarthritis, Knee | 1 | 2023 | 240 | 0.660 |
Why?
| Immunoglobulin M | 2 | 2020 | 275 | 0.650 |
Why?
| RNA Interference | 2 | 2020 | 448 | 0.610 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2023 | 305 | 0.610 |
Why?
| Complement Inactivator Proteins | 3 | 2009 | 41 | 0.600 |
Why?
| Collagen | 6 | 2017 | 434 | 0.600 |
Why?
| Lectins | 2 | 2019 | 46 | 0.590 |
Why?
| Antirheumatic Agents | 1 | 2020 | 278 | 0.580 |
Why?
| Recombinant Fusion Proteins | 4 | 2023 | 643 | 0.580 |
Why?
| Complement Pathway, Classical | 3 | 2014 | 18 | 0.560 |
Why?
| Nanoparticles | 5 | 2024 | 374 | 0.500 |
Why?
| Antibodies, Monoclonal | 5 | 2011 | 1367 | 0.480 |
Why?
| Inflammation | 6 | 2024 | 2736 | 0.480 |
Why?
| Antibodies, Anti-Idiotypic | 1 | 2015 | 57 | 0.470 |
Why?
| Immunoglobulin G | 6 | 2011 | 847 | 0.450 |
Why?
| Adenoviridae | 2 | 2014 | 192 | 0.440 |
Why?
| RNA, Messenger | 9 | 2025 | 2708 | 0.440 |
Why?
| Transcription, Genetic | 1 | 2020 | 1418 | 0.420 |
Why?
| Complement C3a | 2 | 2011 | 41 | 0.420 |
Why?
| Immunization, Passive | 2 | 2018 | 87 | 0.410 |
Why?
| Complement C6 | 2 | 2011 | 9 | 0.410 |
Why?
| Contrast Media | 1 | 2014 | 394 | 0.380 |
Why?
| Adipocytes | 1 | 2013 | 205 | 0.370 |
Why?
| Autoantibodies | 7 | 2023 | 1466 | 0.350 |
Why?
| Autoimmune Diseases | 1 | 2014 | 426 | 0.350 |
Why?
| Collectins | 2 | 2021 | 11 | 0.330 |
Why?
| Complement C5a | 1 | 2009 | 70 | 0.320 |
Why?
| Magnetite Nanoparticles | 4 | 2019 | 27 | 0.320 |
Why?
| Mice, Inbred DBA | 5 | 2020 | 188 | 0.320 |
Why?
| HIV-1 | 6 | 2002 | 836 | 0.310 |
Why?
| Cytokines | 7 | 2021 | 2017 | 0.310 |
Why?
| Complement Factor B | 3 | 2021 | 108 | 0.310 |
Why?
| Humans | 41 | 2025 | 129650 | 0.300 |
Why?
| Disease Models, Animal | 11 | 2021 | 4063 | 0.300 |
Why?
| Polysaccharides | 1 | 2008 | 86 | 0.290 |
Why?
| Fibroblasts | 1 | 2013 | 948 | 0.290 |
Why?
| Complement Inactivating Agents | 2 | 2020 | 45 | 0.290 |
Why?
| Neutrophils | 4 | 2020 | 1205 | 0.270 |
Why?
| Male | 24 | 2025 | 63681 | 0.270 |
Why?
| Blotting, Western | 4 | 2013 | 1205 | 0.250 |
Why?
| Gene Expression | 2 | 2022 | 1472 | 0.250 |
Why?
| Leukocytes | 2 | 2019 | 304 | 0.250 |
Why?
| Complement C1q | 4 | 2009 | 37 | 0.250 |
Why?
| CD4 Antigens | 2 | 1999 | 138 | 0.250 |
Why?
| Sialoglycoproteins | 2 | 2005 | 155 | 0.250 |
Why?
| Complement C3-C5 Convertases | 2 | 2019 | 21 | 0.240 |
Why?
| Cartilage, Articular | 2 | 2006 | 292 | 0.240 |
Why?
| Immunohistochemistry | 4 | 2013 | 1698 | 0.230 |
Why?
| Glycoproteins | 2 | 2003 | 338 | 0.220 |
Why?
| Rheumatoid Factor | 1 | 2025 | 167 | 0.220 |
Why?
| Hydrolases | 2 | 2017 | 56 | 0.220 |
Why?
| Tissue Distribution | 2 | 2022 | 315 | 0.220 |
Why?
| Keratinocytes | 1 | 2005 | 242 | 0.210 |
Why?
| Disease Susceptibility | 2 | 2018 | 333 | 0.210 |
Why?
| Antigens, CD34 | 3 | 2002 | 88 | 0.210 |
Why?
| Cells, Cultured | 4 | 2020 | 4083 | 0.210 |
Why?
| Mannose-Binding Lectin | 2 | 2016 | 22 | 0.200 |
Why?
| Protein Kinases | 1 | 2005 | 318 | 0.200 |
Why?
| Lipopolysaccharides | 3 | 2020 | 875 | 0.200 |
Why?
| Interleukin-18 | 2 | 2003 | 237 | 0.200 |
Why?
| HIV Infections | 6 | 2002 | 2720 | 0.190 |
Why?
| Lupus Erythematosus, Systemic | 3 | 2014 | 247 | 0.190 |
Why?
| Complement C3b Inactivator Proteins | 1 | 2021 | 9 | 0.190 |
Why?
| Thrombin | 2 | 2021 | 146 | 0.190 |
Why?
| Polyethylene Glycols | 2 | 2024 | 601 | 0.190 |
Why?
| Severity of Illness Index | 5 | 2022 | 2742 | 0.190 |
Why?
| Macrophages | 6 | 2015 | 1480 | 0.180 |
Why?
| Proto-Oncogene Proteins | 1 | 2005 | 638 | 0.180 |
Why?
| Trypsin | 1 | 2021 | 74 | 0.180 |
Why?
| Cartilage | 4 | 2019 | 180 | 0.180 |
Why?
| Apoptosis | 4 | 2020 | 2503 | 0.180 |
Why?
| Thymocytes | 1 | 2020 | 33 | 0.170 |
Why?
| Cytotoxicity, Immunologic | 2 | 1998 | 220 | 0.170 |
Why?
| Protein Binding | 5 | 2019 | 2121 | 0.170 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 101 | 0.170 |
Why?
| Transfection | 2 | 2020 | 911 | 0.160 |
Why?
| CD55 Antigens | 1 | 2019 | 29 | 0.160 |
Why?
| Complement C3 Convertase, Alternative Pathway | 1 | 2018 | 2 | 0.160 |
Why?
| Pancytopenia | 1 | 1999 | 8 | 0.150 |
Why?
| Macular Degeneration | 1 | 2020 | 159 | 0.150 |
Why?
| Lymphocyte Activation | 3 | 2003 | 1106 | 0.150 |
Why?
| Cattle | 3 | 2009 | 976 | 0.150 |
Why?
| Antibodies | 2 | 2019 | 398 | 0.150 |
Why?
| Autoimmunity | 3 | 2016 | 862 | 0.150 |
Why?
| Complement C4 | 2 | 2009 | 24 | 0.150 |
Why?
| Diphtheria Toxin | 1 | 1998 | 64 | 0.150 |
Why?
| Lymphocytes | 1 | 2020 | 377 | 0.150 |
Why?
| Genetic Therapy | 3 | 2008 | 292 | 0.150 |
Why?
| Archaeal Viruses | 1 | 2017 | 6 | 0.140 |
Why?
| Bone Marrow Cells | 1 | 1999 | 300 | 0.140 |
Why?
| Atherosclerosis | 1 | 2021 | 402 | 0.140 |
Why?
| Monocytes | 1 | 2020 | 551 | 0.140 |
Why?
| Female | 13 | 2025 | 68776 | 0.140 |
Why?
| Ferric Compounds | 2 | 2014 | 47 | 0.140 |
Why?
| Surface Properties | 2 | 2015 | 399 | 0.130 |
Why?
| Genetic Variation | 2 | 2021 | 937 | 0.130 |
Why?
| Interleukin-1 | 4 | 2005 | 958 | 0.130 |
Why?
| Bleomycin | 1 | 2018 | 244 | 0.130 |
Why?
| Coated Materials, Biocompatible | 1 | 2016 | 59 | 0.130 |
Why?
| T-Lymphocyte Subsets | 2 | 2003 | 412 | 0.130 |
Why?
| Fetal Blood | 1 | 1998 | 316 | 0.130 |
Why?
| Proteolysis | 1 | 2016 | 166 | 0.130 |
Why?
| Opsonin Proteins | 1 | 2015 | 24 | 0.120 |
Why?
| Benzimidazoles | 1 | 2017 | 162 | 0.120 |
Why?
| Mucin-5B | 1 | 2018 | 217 | 0.120 |
Why?
| Protein Processing, Post-Translational | 1 | 2018 | 455 | 0.120 |
Why?
| Biomarkers | 2 | 2018 | 3973 | 0.120 |
Why?
| Spleen | 4 | 2008 | 507 | 0.120 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 958 | 0.120 |
Why?
| T-Lymphocytes | 4 | 2021 | 1928 | 0.120 |
Why?
| Adult | 7 | 2025 | 35576 | 0.120 |
Why?
| Inflammation Mediators | 1 | 2018 | 505 | 0.120 |
Why?
| Synovial Fluid | 2 | 2011 | 66 | 0.120 |
Why?
| Signal Transduction | 3 | 2020 | 4925 | 0.120 |
Why?
| Polymerase Chain Reaction | 3 | 2020 | 1038 | 0.120 |
Why?
| Gene Expression Regulation | 3 | 2021 | 2548 | 0.120 |
Why?
| Mice, Inbred NZB | 1 | 2014 | 16 | 0.120 |
Why?
| Mice, Inbred MRL lpr | 1 | 2014 | 38 | 0.110 |
Why?
| Middle Aged | 7 | 2025 | 31154 | 0.110 |
Why?
| Ross River virus | 1 | 2014 | 23 | 0.110 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 833 | 0.110 |
Why?
| Peptide Fragments | 1 | 1998 | 692 | 0.110 |
Why?
| Transduction, Genetic | 1 | 2014 | 128 | 0.110 |
Why?
| Alphavirus Infections | 1 | 2014 | 44 | 0.110 |
Why?
| Immunity, Innate | 2 | 2017 | 804 | 0.110 |
Why?
| Species Specificity | 1 | 2014 | 575 | 0.110 |
Why?
| Laser Capture Microdissection | 1 | 2013 | 24 | 0.110 |
Why?
| Intestinal Mucosa | 1 | 2018 | 590 | 0.100 |
Why?
| Lymphocyte Subsets | 2 | 2003 | 84 | 0.100 |
Why?
| Biological Transport | 3 | 2020 | 401 | 0.100 |
Why?
| Genotype | 1 | 2018 | 1839 | 0.100 |
Why?
| Interleukin-8 | 2 | 2005 | 262 | 0.100 |
Why?
| Mice, Inbred NOD | 1 | 2014 | 588 | 0.100 |
Why?
| HIV Envelope Protein gp120 | 1 | 1992 | 57 | 0.100 |
Why?
| Alternative Splicing | 1 | 2014 | 218 | 0.100 |
Why?
| Carotid Artery Thrombosis | 1 | 2011 | 7 | 0.100 |
Why?
| Mice, Inbred BALB C | 3 | 2021 | 1245 | 0.090 |
Why?
| Knee Joint | 1 | 2015 | 371 | 0.090 |
Why?
| Complement Membrane Attack Complex | 1 | 2011 | 37 | 0.090 |
Why?
| Liver | 1 | 2020 | 1839 | 0.090 |
Why?
| HIV | 1 | 1992 | 226 | 0.090 |
Why?
| Aged | 3 | 2025 | 22103 | 0.090 |
Why?
| Amidines | 1 | 2011 | 16 | 0.090 |
Why?
| Ornithine | 1 | 2011 | 26 | 0.090 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 636 | 0.090 |
Why?
| Gastrointestinal Microbiome | 1 | 2018 | 641 | 0.090 |
Why?
| RNA, Catalytic | 2 | 2002 | 185 | 0.090 |
Why?
| Doxorubicin | 2 | 2024 | 325 | 0.090 |
Why?
| Lymph Nodes | 3 | 2008 | 472 | 0.080 |
Why?
| Blood Coagulation | 1 | 2011 | 238 | 0.080 |
Why?
| Acquired Immunodeficiency Syndrome | 3 | 1999 | 227 | 0.080 |
Why?
| Interleukin-6 | 2 | 2005 | 720 | 0.080 |
Why?
| Binding Sites | 2 | 2021 | 1252 | 0.080 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2004 | 1198 | 0.080 |
Why?
| Osteoarthritis | 1 | 2011 | 167 | 0.080 |
Why?
| Cardiovascular Diseases | 1 | 2021 | 2004 | 0.080 |
Why?
| Receptors, CCR5 | 2 | 2000 | 57 | 0.080 |
Why?
| Serum | 1 | 2009 | 58 | 0.080 |
Why?
| Foot | 1 | 2009 | 93 | 0.080 |
Why?
| Drug Combinations | 1 | 2009 | 330 | 0.070 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 1994 | 1056 | 0.070 |
Why?
| Zymosan | 1 | 2007 | 65 | 0.070 |
Why?
| Immune Sera | 1 | 2007 | 86 | 0.070 |
Why?
| Cations, Divalent | 1 | 2007 | 56 | 0.070 |
Why?
| Enzyme Inhibitors | 1 | 2011 | 827 | 0.070 |
Why?
| Peptides | 1 | 2013 | 925 | 0.070 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 2 | 2005 | 252 | 0.070 |
Why?
| B-Lymphocytes | 1 | 2012 | 815 | 0.070 |
Why?
| Immunosuppressive Agents | 1 | 2011 | 853 | 0.060 |
Why?
| Gene Transfer Techniques | 3 | 2008 | 163 | 0.060 |
Why?
| DNA | 1 | 2012 | 1400 | 0.060 |
Why?
| Interferon-gamma | 3 | 2004 | 770 | 0.060 |
Why?
| Calcium | 2 | 2012 | 1213 | 0.060 |
Why?
| COP9 Signalosome Complex | 1 | 2005 | 5 | 0.060 |
Why?
| Phosphorylation | 2 | 2012 | 1713 | 0.060 |
Why?
| Two-Hybrid System Techniques | 1 | 2005 | 56 | 0.060 |
Why?
| Lung | 1 | 2018 | 3930 | 0.060 |
Why?
| Extracellular Fluid | 1 | 2004 | 31 | 0.060 |
Why?
| Mice, SCID | 3 | 2002 | 351 | 0.060 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 375 | 0.060 |
Why?
| Immunoglobulins | 1 | 2024 | 159 | 0.060 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 274 | 0.050 |
Why?
| Citrulline | 2 | 2017 | 44 | 0.050 |
Why?
| Rats | 2 | 2023 | 5500 | 0.050 |
Why?
| Injections, Intradermal | 1 | 2003 | 13 | 0.050 |
Why?
| Cross-Linking Reagents | 2 | 2015 | 205 | 0.050 |
Why?
| HeLa Cells | 1 | 2005 | 608 | 0.050 |
Why?
| In Vitro Techniques | 1 | 2005 | 1085 | 0.050 |
Why?
| Hindlimb | 1 | 2003 | 122 | 0.050 |
Why?
| Lymphocyte Count | 1 | 2003 | 148 | 0.050 |
Why?
| Receptors, CXCR4 | 2 | 2002 | 83 | 0.050 |
Why?
| Superoxide Dismutase | 1 | 2004 | 342 | 0.050 |
Why?
| Cell Count | 1 | 2003 | 314 | 0.050 |
Why?
| Recombinant Proteins | 1 | 2005 | 1304 | 0.050 |
Why?
| Blood Sedimentation | 1 | 2021 | 34 | 0.050 |
Why?
| Chromosome Deletion | 1 | 2021 | 104 | 0.050 |
Why?
| Homozygote | 1 | 2021 | 193 | 0.050 |
Why?
| Mice, Transgenic | 2 | 2003 | 2119 | 0.050 |
Why?
| Rats, Long-Evans | 1 | 2021 | 135 | 0.050 |
Why?
| Sequence Deletion | 1 | 2021 | 179 | 0.050 |
Why?
| Antigen-Presenting Cells | 1 | 2021 | 150 | 0.040 |
Why?
| Necrosis | 1 | 2021 | 232 | 0.040 |
Why?
| Hematopoietic Stem Cells | 2 | 2002 | 381 | 0.040 |
Why?
| Interleukin-10 | 1 | 2002 | 304 | 0.040 |
Why?
| Bone and Bones | 2 | 2017 | 299 | 0.040 |
Why?
| Organ Specificity | 2 | 2016 | 296 | 0.040 |
Why?
| Gene Expression Profiling | 2 | 2021 | 1706 | 0.040 |
Why?
| Dogs | 1 | 2021 | 381 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 1 | 2021 | 372 | 0.040 |
Why?
| Retinal Pigment Epithelium | 1 | 2020 | 69 | 0.040 |
Why?
| Nuclear Proteins | 1 | 2005 | 663 | 0.040 |
Why?
| Adaptive Immunity | 1 | 2021 | 161 | 0.040 |
Why?
| Choroidal Neovascularization | 1 | 2020 | 55 | 0.040 |
Why?
| Tomography, Optical Coherence | 1 | 2020 | 187 | 0.040 |
Why?
| Ferrosoferric Oxide | 1 | 2019 | 23 | 0.040 |
Why?
| HIV Seronegativity | 1 | 1999 | 25 | 0.040 |
Why?
| Cardiology | 1 | 2021 | 261 | 0.040 |
Why?
| Nanomedicine | 1 | 2019 | 31 | 0.040 |
Why?
| C-Reactive Protein | 1 | 2021 | 401 | 0.040 |
Why?
| Fetal Tissue Transplantation | 1 | 1998 | 35 | 0.040 |
Why?
| Fluorescent Dyes | 1 | 2020 | 317 | 0.040 |
Why?
| Clone Cells | 1 | 1999 | 261 | 0.040 |
Why?
| A549 Cells | 1 | 2018 | 59 | 0.040 |
Why?
| Tobacco Products | 1 | 2019 | 110 | 0.040 |
Why?
| HIV Seropositivity | 1 | 1999 | 119 | 0.040 |
Why?
| Anti-Citrullinated Protein Antibodies | 1 | 2019 | 109 | 0.040 |
Why?
| Extremophiles | 1 | 2017 | 2 | 0.040 |
Why?
| Proteomics | 2 | 2017 | 1062 | 0.040 |
Why?
| Lipids | 1 | 2021 | 625 | 0.040 |
Why?
| Sulfolobus | 1 | 2017 | 11 | 0.040 |
Why?
| HLA-DR Antigens | 1 | 1999 | 224 | 0.040 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3628 | 0.040 |
Why?
| Immunity, Mucosal | 1 | 2018 | 94 | 0.030 |
Why?
| Rabbits | 1 | 2018 | 778 | 0.030 |
Why?
| Microscopy, Electron, Transmission | 1 | 2017 | 146 | 0.030 |
Why?
| Drug Delivery Systems | 1 | 2020 | 336 | 0.030 |
Why?
| Epitopes | 1 | 2019 | 470 | 0.030 |
Why?
| Phylogeny | 1 | 2021 | 852 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2021 | 2058 | 0.030 |
Why?
| Oxygen | 1 | 2021 | 915 | 0.030 |
Why?
| Protein Conformation | 1 | 2019 | 859 | 0.030 |
Why?
| Sheep | 1 | 2018 | 837 | 0.030 |
Why?
| RNA, Ribosomal, 16S | 1 | 2018 | 525 | 0.030 |
Why?
| Repressor Proteins | 1 | 2019 | 406 | 0.030 |
Why?
| RNA-Binding Proteins | 1 | 2019 | 388 | 0.030 |
Why?
| Sodium Hydroxide | 1 | 2014 | 8 | 0.030 |
Why?
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2015 | 74 | 0.030 |
Why?
| Endocytosis | 1 | 2015 | 163 | 0.030 |
Why?
| Half-Life | 1 | 2014 | 162 | 0.030 |
Why?
| Simian Acquired Immunodeficiency Syndrome | 1 | 1995 | 83 | 0.030 |
Why?
| Promoter Regions, Genetic | 1 | 2018 | 1207 | 0.030 |
Why?
| Diagnostic Imaging | 1 | 2016 | 334 | 0.030 |
Why?
| Particle Size | 1 | 2014 | 355 | 0.030 |
Why?
| Molecular Targeted Therapy | 1 | 2016 | 390 | 0.030 |
Why?
| Gamma Rays | 1 | 1992 | 54 | 0.020 |
Why?
| Blood Platelets | 1 | 2015 | 380 | 0.020 |
Why?
| Surface Plasmon Resonance | 1 | 2012 | 88 | 0.020 |
Why?
| Mannose-Binding Lectins | 1 | 2011 | 11 | 0.020 |
Why?
| CD59 Antigens | 1 | 2011 | 20 | 0.020 |
Why?
| Matrix Metalloproteinase 13 | 1 | 2011 | 23 | 0.020 |
Why?
| Clonal Anergy | 1 | 2012 | 51 | 0.020 |
Why?
| Smoking | 1 | 2019 | 1501 | 0.020 |
Why?
| Epidermolysis Bullosa Acquisita | 1 | 2011 | 6 | 0.020 |
Why?
| Temperature | 1 | 2014 | 636 | 0.020 |
Why?
| Case-Control Studies | 1 | 2019 | 3381 | 0.020 |
Why?
| Pemphigoid, Bullous | 1 | 2011 | 8 | 0.020 |
Why?
| DNA-Binding Proteins | 1 | 2019 | 1443 | 0.020 |
Why?
| Disease Progression | 1 | 2019 | 2635 | 0.020 |
Why?
| Receptors, Antigen, B-Cell | 1 | 2012 | 126 | 0.020 |
Why?
| Protein-Arginine Deiminases | 1 | 2011 | 16 | 0.020 |
Why?
| Chlorides | 1 | 2011 | 139 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 169 | 0.020 |
Why?
| Body Mass Index | 1 | 2019 | 2273 | 0.020 |
Why?
| DNA Damage | 1 | 1992 | 384 | 0.020 |
Why?
| Immunoglobulin A | 1 | 2011 | 200 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2012 | 840 | 0.020 |
Why?
| Chondrocytes | 1 | 2011 | 203 | 0.020 |
Why?
| Base Sequence | 2 | 2003 | 2142 | 0.020 |
Why?
| Peptides, Cyclic | 1 | 2011 | 256 | 0.020 |
Why?
| Mice, Inbred Strains | 1 | 2008 | 406 | 0.020 |
Why?
| Genetic Vectors | 1 | 2008 | 312 | 0.020 |
Why?
| Adiponectin | 1 | 2008 | 235 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2012 | 3083 | 0.010 |
Why?
| Chemokine CXCL2 | 1 | 2003 | 43 | 0.010 |
Why?
| Phenotype | 1 | 2012 | 3076 | 0.010 |
Why?
| Antibody Formation | 1 | 2004 | 290 | 0.010 |
Why?
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 6 | 0.010 |
Why?
| Gene Products, rev | 1 | 2002 | 6 | 0.010 |
Why?
| Gene Products, tat | 1 | 2002 | 21 | 0.010 |
Why?
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 22 | 0.010 |
Why?
| Mitogens | 1 | 2002 | 58 | 0.010 |
Why?
| Chemokines | 1 | 2003 | 226 | 0.010 |
Why?
| DNA Primers | 1 | 2003 | 510 | 0.010 |
Why?
| Gene Expression Regulation, Viral | 1 | 2002 | 90 | 0.010 |
Why?
| Protein Isoforms | 1 | 2003 | 391 | 0.010 |
Why?
| Thymus Gland | 1 | 2002 | 306 | 0.010 |
Why?
| Cell Lineage | 1 | 2002 | 333 | 0.010 |
Why?
| CCR5 Receptor Antagonists | 1 | 2000 | 6 | 0.010 |
Why?
| Colony-Forming Units Assay | 1 | 2000 | 90 | 0.010 |
Why?
| Immunophenotyping | 1 | 2000 | 311 | 0.010 |
Why?
| Down-Regulation | 1 | 2000 | 636 | 0.010 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 573 | 0.010 |
Why?
| Cell Line | 1 | 2002 | 2781 | 0.010 |
Why?
| Liver Transplantation | 1 | 2002 | 831 | 0.010 |
Why?
| Macaca | 1 | 1995 | 54 | 0.010 |
Why?
| Cell Differentiation | 1 | 2002 | 1902 | 0.010 |
Why?
| Simian Immunodeficiency Virus | 1 | 1995 | 85 | 0.010 |
Why?
| RNA, Viral | 1 | 1995 | 619 | 0.010 |
Why?
| Child, Preschool | 1 | 1995 | 10517 | 0.000 |
Why?
| Child | 1 | 1995 | 20883 | 0.000 |
Why?
|
|
Banda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|